Real-World check: combo cholesterol pill works in daily practice
NCT ID NCT05559606
First seen Jun 26, 2026 · Last updated Jun 26, 2026
Summary
This completed study observed 1,839 adults with primary high cholesterol who were prescribed a fixed-dose combination of atorvastatin and ezetimibe for 24 weeks. Researchers collected data on how well the pill lowered LDL cholesterol and tracked any safety issues. The goal was to see if this combo therapy works as well in everyday clinics as it does in controlled trials.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
atorvastatin and ezetimibe combination pill
What this could lead to
If results are positive, this could confirm that the fixed-dose combo pill is a safe and effective option for managing high cholesterol in everyday patients.
What could go wrong
This is an observational study, not a controlled trial, so results may be less reliable. It only lasted 24 weeks, so long-term safety and benefits are not assessed.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PRIMARY HYPERCHOLESTEROLEMIA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Severance Hospital, Yonsei University Health System
Seoul, South Korea